Abhijit Lele &Amp; Sohini Das

Stories by Abhijit Lele &Amp; Sohini Das

Indian Biz Sees Hope After Bangladesh SC Order

Indian Biz Sees Hope After Bangladesh SC Order

Rediff.com   22 Jul 2024

'Bilateral trade has suffered seriously because of the growing unrest.' 'There is a standstill on both sides amid the curfew.'

Nipah Death Puts Kerala On Alert

Nipah Death Puts Kerala On Alert

Rediff.com   22 Jul 2024

The scare of communicable diseases seems to be gripping the country with Maharashtra reporting 28 Zika cases this year, the highest since 2021.

Downpour Of Diseases In India

Downpour Of Diseases In India

Rediff.com   20 Jul 2024

Kerala has had 202 fatalities in 2024 so far. In July alone, there were 202,122 episodes of fever, 2,250 cases of dengue, 1,850 cases of mumps and several other illnesses. 10,000 cases of dengue have been reported from Karnataka. 1,000 swine flu cases have been documented in Rajasthan.

Honda 2W share rises after on-board norms compliance

Honda 2W share rises after on-board norms compliance

Rediff.com   17 Jul 2024

The battle for the top spot in the two-wheeler market is intensifying. The gap between Hero MotoCorp and Honda Motorcycle & Scooter India (HMSI) in retail sales narrowed to just 45,607 units in June. This improvement comes as HMSI has clawed back market share after dipping to a historic low of 18 per cent in May 2023. Now, the retail market shares of the two companies are 28.86 per cent and 25.54 per cent, respectively, compared to 35.54 per cent and 18.05 per cent in May 2023.

Diabetes Drug Linked To Vision Loss?

Diabetes Drug Linked To Vision Loss?

Rediff.com   16 Jul 2024

Study suggested that constant use of Semaglutide may be linked to development of a condition called non-arteritic ischemic optic neuropathy.

Tyger Capital to list by next year, targets Rs 20,000 crore book

Tyger Capital to list by next year, targets Rs 20,000 crore book

Rediff.com   12 Jul 2024

Bain Capital-backed Tyger Capital is planning to list its shares on the Indian stock exchanges by the next financial year and is targeting to grow its assets under management by four times to Rs 20,000 crore in five years from Rs 5,000 crore now, Gaurav Gupta, MD and CEO of the firm said. In an exclusive interview, Gupta said that keeping with the growing business, the finance company expects to on-board 600 people in the current financial year as it is opening 60-65 new branches for broad-basing its network in the country.

Result preview: Cost of deposits to weigh on banks' margins in Q1

Result preview: Cost of deposits to weigh on banks' margins in Q1

Rediff.com   12 Jul 2024

Despite steady loan growth, the banking sector is expected to report subdued margins in the quarter ending June 2024 (Q1FY25), driven by high demand for deposits amidst tight liquidity conditions. However, according to Bloomberg analysts, listed banks are forecasted to see a 14.5 per cent year-on-year (Y-o-Y) increase in net profit. Estimates showed that banks' net interest income (NII), and revenues from interest minus interest expenses might grow 11.9 per cent Y-o-Y.

How Kalki's Bujji Was Born

How Kalki's Bujji Was Born

Rediff.com   1 Jul 2024

'Fun stuff does, indeed, happen on X.'

C S Setty: SBI's New Boss

C S Setty: SBI's New Boss

Rediff.com   1 Jul 2024

'You will see him frequently asking customers -- especially retail -- about service experience, pain points, areas of improvement and suggestions.'

Quality Lapses Shut Down Drug Makers

Quality Lapses Shut Down Drug Makers

Rediff.com   28 Jun 2024

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.

Bharat Biotech finally names ICMR as co-owner in Covaxin patent filings

Bharat Biotech finally names ICMR as co-owner in Covaxin patent filings

Rediff.com   25 Jun 2024

After reports claimed that filings in patent offices in India, the US, and Europe did not mention ICMR or its scientists, but only BBIL and its scientists, the Hyderabad-based biotechnology (biotech) company clarified that in the "rush" to develop vaccines and file appropriate patents, BBIL had missed adding ICMR's name in the original filings.

Cleaner Fuels Driving One-Fifth Of PVs Sold In India

Cleaner Fuels Driving One-Fifth Of PVs Sold In India

Rediff.com   18 Jun 2024

Auto manufacturers have focused on launching CNG variants of their popular models to meet consumer demand for vehicles with lower running costs.

'Second-gen promoters more open to selling out'

'Second-gen promoters more open to selling out'

Rediff.com   6 Jun 2024

'There is not any negative connotation associated with it.'

'Depending on the product, the pricing pressure will always be there'

'Depending on the product, the pricing pressure will always be there'

Rediff.com   3 Jun 2024

'That is a significant milestone for us and something we aspired for.'

New-Gen COVID Jabs Coming Soon...

New-Gen COVID Jabs Coming Soon...

Rediff.com   28 May 2024

India currently does not have any XBB 1.5 variant-based vaccines available.

Jio Fin arm plans Rs 36K cr deal with Reliance Retail

Jio Fin arm plans Rs 36K cr deal with Reliance Retail

Rediff.com   27 May 2024

Mukesh Ambani's Jio Financial Services (JFS) is set to seek shareholders' approval for its leasing subsidiary to acquire telecom equipment and devices worth Rs 36,000 crore ($4.33 billion) from Reliance Retail. Jio Leasing Services Limited (JLSL), a wholly-owned subsidiary of JFS, plans to enter the device leasing business, and the equipment will be deployed in broadband wireless connectivity and other services.

'Liquidity will improve in system after elections'

'Liquidity will improve in system after elections'

Rediff.com   24 May 2024

'We may see little softness in liquidity position after the stabilisation of the government.'

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Rediff.com   23 May 2024

Several firms are stepping up to help their workforce cope with soaring temperatures

Should Govt Continue Covid Vax Drive?

Should Govt Continue Covid Vax Drive?

Rediff.com   20 May 2024

India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities.

M&M shifts to high gear with Rs 37K cr investments

M&M shifts to high gear with Rs 37K cr investments

Rediff.com   17 May 2024

Automotive (auto) major Mahindra & Mahindra (M&M), which is readying to launch nine sport utility vehicles (internal combustion engine/ICE), seven Born Electric Vehicles (BEVs), and seven light commercial vehicles by 2030, has outlined an investment of Rs 27,000 crore in its auto business between 2024-25 (FY25) and 2026-27 (FY27). Over the next three years, the company will deploy Rs 37,000 crore, including its auto business, farm business (Rs 5,000 crore), and service business (Rs 5,000 crore).